Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
iChip01:24

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomimetic Nanoplatform for Dual Target Nano-Metabolic Therapy in Diabetes-Associated Biofilm Infections.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Development and Internal Evaluation of a Biomarker-Based Model for Preoperative Diagnosis of Infectious Nonunion.

Orthopaedic surgery·2026
Same author

The Distally Based Saphenous Neurocutaneous Perforator Flap: A Versatile Donor Site for Reconstruction of Complex Soft Tissue Defects of the Lower Leg.

Annals of plastic surgery·2026
Same author

Coupling EPR spin trapping of hydroxyethyl radicals and Strecker aldehydes analysis for predicting oxidative susceptibility of Chardonnay wines.

Current research in food science·2026
Same author

Intraosseous Abscess from Subacute Osteomyelitis.

The New England journal of medicine·2026
Same author

Correction to: PET/MRI as a complement to PET/CT in chronic osteomyelitis with soft-tissue involvement: implications for surgical outcomes.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Conformational dynamics of pneumococcal polysaccharide conjugates drive UV-vis quantification errors and a strategy to enable UV-vis spectrophotometer quantification.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting report.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Longevity of humoral response in recipients of rabies pre-exposure prophylactic vaccination with Abhayrab®.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Collaborative studies to establish WHO International Reference Reagents for diphtheria and tetanus antitoxin for use in the flocculation test.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting report.

Biologicals : journal of the International Association of Biological Standardization·2026
Same journal

Leveraging analytical and bioprocess platforms for biological product development and commercialization - A meeting report.

Biologicals : journal of the International Association of Biological Standardization·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

China's growing biomedical industry.

Pei Han1

  • 1Editorial Office, Chinese Journal of New Drugs, Beijing, China. ph_ohi@tom.com

Biologicals : Journal of the International Association of Biological Standardization
|May 12, 2009
PubMed
Summary
This summary is machine-generated.

China's biomedical sector is growing, with biological drugs gaining traction. Despite being a major vaccine producer, demand outstrips supply, indicating significant growth potential for biopharmaceuticals.

More Related Videos

Developing Custom Chinese Hamster Ovary-host Cell Protein Assays using Acoustic Membrane Microparticle Technology
07:13

Developing Custom Chinese Hamster Ovary-host Cell Protein Assays using Acoustic Membrane Microparticle Technology

Published on: February 3, 2011

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

Developing Custom Chinese Hamster Ovary-host Cell Protein Assays using Acoustic Membrane Microparticle Technology
07:13

Developing Custom Chinese Hamster Ovary-host Cell Protein Assays using Acoustic Membrane Microparticle Technology

Published on: February 3, 2011

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

Area of Science:

  • Biomedical industry
  • Pharmaceutical market analysis
  • Biopharmaceutical development

Background:

  • China's biomedical industry is experiencing rapid expansion.
  • Biological drugs are increasing their market share, driven by public health needs.
  • China leads global vaccine production and usage, yet faces supply shortages.

Purpose of the Study:

  • To analyze the current state and future potential of China's biopharmaceutical market.
  • To identify growth opportunities within the rapidly evolving biomedical sector.
  • To assess the market dynamics between biological drugs and traditional medicines in China.

Main Methods:

  • Market analysis of China's pharmaceutical sector.
  • Review of biological drug and vaccine production versus market demand.
  • Comparative analysis of biopharmaceutical market size against traditional medicines.

Main Results:

  • Biological drugs are a growing segment of China's pharmaceutical market.
  • Vaccine production capacity is insufficient to meet market demand.
  • The biopharmaceutical market is currently smaller than traditional and chemical medicine markets.

Conclusions:

  • China's biopharmaceutical industry shows substantial potential for future growth.
  • Addressing vaccine supply gaps presents a significant market opportunity.
  • Biopharmaceuticals are poised to become a leading sector in China's healthcare market.